Frederik Giesel

Scientific Advisor at Telix Pharma

Frederik Giesel studied medicine at the Universities of Mainz and Heidelberg in Germany. After graduating from medical school, Dr. Giesel went to the National Institutes of Health (NIH) in Bethesda, Maryland (USA) during his residency. He also holds an executive MBA-program at the Frankfurt School of Finance in Germany. Since 2015, Dr. Giesel has served as a professor of radiology and vice chair for nuclear medicine at the University Hospital Heidelberg, and was recently a visiting professor at Stanford University in the United States and Yonsei University in South Korea. He published over 200 original articles and over 600 scientific abstract on international scientific conferences with an H-Index of 43. Today, Dr. Giesel leads the phase I/II DKTK multi center study of a new PET tracer, which has been introduced into the clinical environment for prostate cancer patients (PSMA).

Timeline

  • Scientific Advisor

    Current role